Skip to content
healthcare.dev

Buprenorphine and Naloxone

NDC 3215-6523, buprenorphine and naloxone, film, from Aveva Drug Delivery Systems Inc..

Product NDC
3215-6523
Status
Listed
Labeler
Aveva Drug Delivery Systems Inc.
Dosage form
FILM
Route
BUCCAL, SUBLINGUAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212756
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/3215-6523 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPRENORPHINE HYDROCHLORIDE8 mg/1
  • NALOXONE HYDROCHLORIDE2 mg/1

Pharmacologic classes

Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]

Package NDCNDC-11Package
3215-6523-300321565233030 POUCH in 1 CARTON (3215-6523-30) / 1 FILM in 1 POUCH (3215-6523-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/cb112448-49a1-4209-bcdb-7cfae6501f51

Use it

Look up 3215-6523 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/3215-6523 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 3215-6523. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.